Clinical Trials Browser

Phase 2 × Lymphoma × tislelizumab × Clear all

NCT05977673 2025-12-08

FIL_Tisle-HL

Phase 2 Recruiting

Hodgkin Disease, Lymphoma

NCT05477264 2024-04-03

Concurrent Tislelizumab and Radiotherapy in Newly Diagnosed Extranodal NK/T-cell Lymphoma, Nasal Type

Phase 2 Recruiting

Lymphoma